Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Is the Current and Projected Market Size of the Embolotherapy Market Through 2034?
The market size for embolotherapy has seen robust expansion in the past years. Its value is expected to increase from $4.44 billion in 2024 to $4.86 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. Elements contributing to the past period growth include a surge in the need for embolotherapy treatments, an escalating number of cancer cases, the rising prevalence of peripheral vascular diseases, increasing healthcare spending, and burgeoning investments aimed at research.
In the following years, the embolotherapy market is projected to experience significant expansion, reaching a value of $6.83 billion in 2029 with a compound annual growth rate (CAGR) of 8.9%. This increase during the forecasted period is due to several factors such as an increase in disposable income, a rise in chronic disease prevalence, the expansion of its use in reproductive health, an uptick in cheoembolization procedures, and a growing incidence of liver cancer. The forecasted period will also see significant trends like advanced technologies, digital and analog devices, the inclusion of an insertable cardiac monitor, embolotherapy techniques, and strategic partnerships.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21181&type=smp
What External and Internal Drivers Are Contributing to the Growth of the Embolotherapy Market?
The embolotherapy market is expected to expand due to the increased preference for minimally invasive procedures. These are cosmetic treatments that involve little to no surgical intervention, leading to less downtime and lower risks. The popularity of these procedures stems from quicker recovery times, less pain, fewer scars, diminished risk of complications, and ongoing technological developments. Embolotherapy contributes to the efficacy of minimally invasive procedures by specifically blocking blood circulation to specific vessels. This helps reduce bleeding, treat tumors, and control vascular irregularities more accurately and with fewer complications. According to the American Society of Plastic Surgeons, a non-profit organization based in the USA, there was a 7% increase in cosmetic minimally invasive procedures by September 2023, resulting in a rise from 23,672,269 in 2022 to 25,442,640. Consequently, this growing inclination towards minimally invasive procedures is fuelling the expansion of the embolotherapy market.
What Segment Types Define the Embolotherapy Market Structure?
The embolotherapy market covered in this report is segmented –
1) By Product: Embolization Coil, Embolic Agents, Detachable Balloons, Embolic Plug Systems, Support Devices
2) By Application: Oncology, Peripheral Vascular Diseases, Urology and Nephrology, Neurology, Gastrointestinal (GIT) Disorders
3) By Procedure: Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT), Transarterial Chemoembolization (TACE)
4) By End User: Ambulatory Surgical Centre, Hospitals And Clinics, Other End Users
Subsegments:
1) By Embolization Coil: Bare Coils, Coated Coils, Micro Coils
2) By Embolic Agents: Liquid Embolic Agents, Particulate Embolic Agents, Gelatin Sponge, Polyvinyl Alcohol (PVA) Particles
3) By Detachable Balloons: Single-Use Balloons, Multi-Use Balloons
4) By Embolic Plug Systems: Plug Kits, Distal Occlusion Systems
5) By Support Devices: Guidewires, Catheters, Sheath Introducers
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21181&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Embolotherapy Market?
North America was the largest region in the embolotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the embolotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Long-Term Trends Are Transforming the Competitive Landscape of the Embolotherapy Market?
Leading firms in the embolotherapy field are striving to develop revolutionary products like absorbable embolics systems to improve patient results and widen the range of treatment alternatives. Absorbable embolic systems utilize bioresorbable materials in embolization procedures to hinder blood supply to specific tissues such as tumors or aneurysms, and these materials eventually disintegrate within the body. To illustrate, in January 2025, Instylla Inc., a medical equipment manufacturer based in the U.S., obtained FDA 510(k) approval for its bioresorbable embolization agent named Tembo embolic system, constructed with dry-gelatin particles irregular in shape and ranging from 85 to 255 µm in size. This system is engineered to embolize hypervascular tumors and seal off blood vessels in the peripheral vasculature. As per Instylla, Tembo provides benefits like simple preparation, high visibility, and the capability to densely fill treated vessels, potentially enhancing the efficacy of existing permanent embolic solutions.
View the full report here:
https://www.thebusinessresearchcompany.com/report/embolotherapy-global-market-report
What Is the Definition of the Embolotherapy Market?
Embolotherapy is a minimally invasive medical procedure involving intentionally blocking blood vessels to treat various medical conditions. It is achieved by injecting embolic agents, such as microspheres, coils, gels, or liquid embolic, into targeted blood vessels to cut off blood supply to abnormal tissues or structures. Embolotherapy is a highly targeted and less invasive alternative to traditional surgery, often performed by interventional radiologists to improve patient outcomes with minimal recovery time.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21181
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model